These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 23917280)

  • 41. Genome sequencing and carrier testing: decisions on categorization and whether to disclose results of carrier testing.
    Himes P; Kauffman TL; Muessig KR; Amendola LM; Berg JS; Dorschner MO; Gilmore M; Nickerson DA; Reiss JA; Richards CS; Rope AF; Simpson DK; Wilfond BS; Jarvik GP; Goddard KAB
    Genet Med; 2017 Jul; 19(7):803-808. PubMed ID: 28079899
    [TBL] [Abstract][Full Text] [Related]  

  • 42. ACMG recommendations on incidental findings are flawed scientifically and ethically.
    Holtzman NA
    Genet Med; 2013 Sep; 15(9):750-1. PubMed ID: 24008255
    [No Abstract]   [Full Text] [Related]  

  • 43. How do clinical genetics consent forms address the familial approach to confidentiality and incidental findings? A mixed-methods study.
    Dheensa S; Crawford G; Salter C; Parker M; Fenwick A; Lucassen A
    Fam Cancer; 2018 Jan; 17(1):155-166. PubMed ID: 28405783
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Military Health Care Dilemmas and Genetic Discrimination: A Family's Experience with Whole Exome Sequencing.
    Helm BM; Langley K; Spangler BB; Schrier Vergano SA
    Narrat Inq Bioeth; 2015; 5(2):179-86. PubMed ID: 26300150
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Patient decisions for disclosure of secondary findings among the first 200 individuals undergoing clinical diagnostic exome sequencing.
    Shahmirzadi L; Chao EC; Palmaer E; Parra MC; Tang S; Gonzalez KD
    Genet Med; 2014 May; 16(5):395-9. PubMed ID: 24113345
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Informed consent in direct-to-consumer personal genome testing: the outline of a model between specific and generic consent.
    Bunnik EM; Janssens AC; Schermer MH
    Bioethics; 2014 Sep; 28(7):343-51. PubMed ID: 23137034
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Processes and preliminary outputs for identification of actionable genes as incidental findings in genomic sequence data in the Clinical Sequencing Exploratory Research Consortium.
    Berg JS; Amendola LM; Eng C; Van Allen E; Gray SW; Wagle N; Rehm HL; DeChene ET; Dulik MC; Hisama FM; Burke W; Spinner NB; Garraway L; Green RC; Plon S; Evans JP; Jarvik GP;
    Genet Med; 2013 Nov; 15(11):860-7. PubMed ID: 24195999
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Incidental variants are critical for genomics.
    Biesecker LG
    Am J Hum Genet; 2013 May; 92(5):648-51. PubMed ID: 23643378
    [TBL] [Abstract][Full Text] [Related]  

  • 49. What would you do?: an investigation into Jewish biomedical ethics.
    Kenigsberg K; Reisner AI; Davidowitz-Farkas Z; Fins JJ; Breitowitz YA; Grumet Z; Berkowitz AK
    Shma; 1995 Sep; 26(496):1-8. PubMed ID: 11660114
    [No Abstract]   [Full Text] [Related]  

  • 50. Genetic testing: clinical and personal utility.
    Mills RA; Haga SB; Ginsburg GS
    Virtual Mentor; 2012 Aug; 14(8):604-9. PubMed ID: 23351313
    [No Abstract]   [Full Text] [Related]  

  • 51. Reconceptualising the Interest in Knowing One's Origins: A Case for Mandatory Disclosure.
    Wade K
    Med Law Rev; 2020 Dec; 28(4):731-752. PubMed ID: 33118029
    [TBL] [Abstract][Full Text] [Related]  

  • 52. A closer look revisited: are we subjects or are we donors?
    Fisher R
    Genet Med; 2012 Apr; 14(4):458-60. PubMed ID: 22361901
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Genomics and health care. How genomics medicine is translated into better health care largely depends on how physicians handle this information.
    Brower V
    EMBO Rep; 2004 Feb; 5(2):131-3. PubMed ID: 14755303
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Guidelines support the return of incidental genomic findings: recommendation suggests that labs should report children’s mutations associated with certain adult-onset diseases.
    Levenson D
    Am J Med Genet A; 2013 Jun; 161A(6):vii-viii. PubMed ID: 23844426
    [No Abstract]   [Full Text] [Related]  

  • 55. Clinical tumor sequencing: an incidental casualty of the American College of Medical Genetics and Genomics recommendations for reporting of incidental findings.
    Parsons DW; Roy A; Plon SE; Roychowdhury S; Chinnaiyan AM
    J Clin Oncol; 2014 Jul; 32(21):2203-5. PubMed ID: 24958819
    [No Abstract]   [Full Text] [Related]  

  • 56. Issues in genetic testing of children.
    Twomey JG
    MCN Am J Matern Child Nurs; 2006; 31(3):156-63. PubMed ID: 16679956
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Next Generation DNA Sequencing: Always Allow an Opt Out.
    Bredenoord AL; Bijlsma RM; van Delden H
    Am J Bioeth; 2015; 15(7):28-30. PubMed ID: 26147261
    [No Abstract]   [Full Text] [Related]  

  • 58. First, do no harm.
    Leikin S
    Ethics Behav; 1995; 5(2):193-194, 196-199. PubMed ID: 11654200
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Proceed with diligence.
    Elger BS
    J Med Ethics; 2012 Sep; 38(9):529-30; discussion 533-4. PubMed ID: 22767538
    [No Abstract]   [Full Text] [Related]  

  • 60. Different concepts and models of information for family-relevant genetic findings: comparison and ethical analysis.
    Lenk C; Frommeld D
    Med Health Care Philos; 2015 Aug; 18(3):393-408. PubMed ID: 25894235
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.